Protagonist Cash And Short Term Investments from 2010 to 2024
| PTGX Stock | USD 29.81 1.66 5.90% |
Cash And Short Term Investments | First Reported 2015-03-31 | Previous Quarter 341.6 M | Current Value 322.6 M | Quarterly Volatility 108.6 M |
Check Protagonist Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagonist Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Interest Expense of 4.1 M or Selling General Administrative of 18 M, as well as many indicators such as Price To Sales Ratio of 20.61, Dividend Yield of 0.0 or PTB Ratio of 4.06. Protagonist financial statements analysis is a perfect complement when working with Protagonist Therapeutics Valuation or Volatility modules.
Protagonist | Cash And Short Term Investments |
Latest Protagonist Therapeutics' Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Protagonist Therapeutics over the last few years. Short Term Investments is an account in the current assets section of Protagonist Therapeutics balance sheet. This account contains Protagonist Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Protagonist Therapeutics fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Protagonist Therapeutics' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagonist Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Protagonist Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 131,246,844 | |
| Geometric Mean | 58,316,163 | |
| Coefficient Of Variation | 95.43 | |
| Mean Deviation | 103,310,634 | |
| Median | 128,853,000 | |
| Standard Deviation | 125,253,632 | |
| Sample Variance | 15688.5T | |
| Range | 332.3M | |
| R-Value | 0.87 | |
| Mean Square Error | 3976.2T | |
| R-Squared | 0.76 | |
| Significance | 0.00002 | |
| Slope | 24,491,074 | |
| Total Sum of Squares | 219638.6T |
Protagonist Cash And Short Term Investments History
About Protagonist Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Protagonist Therapeutics income statement, its balance sheet, and the statement of cash flows. Protagonist Therapeutics investors use historical funamental indicators, such as Protagonist Therapeutics's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Protagonist Therapeutics investors may use each financial statement separately, they are all related. The changes in Protagonist Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Protagonist Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Protagonist Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Protagonist Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 341.6 M | 191.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.